Lipocine, Inc. (LPCN)
1.54
+0.01
(+0.65%)
USD |
NASDAQ |
Nov 06, 09:58
Lipocine Market Cap : 12.70M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 12.61M |
| November 04, 2026 | 11.87M |
| November 03, 2026 | 12.04M |
| November 02, 2026 | 11.95M |
| October 30, 2026 | 11.87M |
| October 29, 2026 | 12.53M |
| October 28, 2026 | 12.45M |
| October 27, 2026 | 12.04M |
| October 26, 2026 | 11.95M |
| October 23, 2026 | 11.87M |
| October 22, 2026 | 12.04M |
| October 21, 2026 | 13.19M |
| October 20, 2026 | 13.36M |
| October 19, 2026 | 12.61M |
| October 16, 2026 | 12.86M |
| October 15, 2026 | 13.85M |
| October 14, 2026 | 13.93M |
| October 13, 2026 | 13.36M |
| October 12, 2026 | 13.69M |
| October 09, 2026 | 14.18M |
| October 08, 2026 | 15.91M |
| October 07, 2026 | 18.14M |
| October 06, 2026 | 17.31M |
| October 05, 2026 | 17.07M |
| October 02, 2026 | 16.90M |
| Date | Value |
|---|---|
| October 01, 2026 | 17.07M |
| September 30, 2026 | 18.14M |
| September 29, 2026 | 17.81M |
| September 28, 2026 | 17.23M |
| September 25, 2026 | 17.31M |
| September 24, 2026 | 17.23M |
| September 23, 2026 | 17.48M |
| September 22, 2026 | 17.81M |
| September 21, 2026 | 18.47M |
| September 18, 2026 | 18.22M |
| September 17, 2026 | 18.30M |
| September 16, 2026 | 17.81M |
| September 15, 2026 | 18.01M |
| September 14, 2026 | 18.30M |
| September 11, 2026 | 18.71M |
| September 10, 2026 | 18.55M |
| September 09, 2026 | 18.55M |
| September 08, 2026 | 19.46M |
| September 04, 2026 | 20.20M |
| September 03, 2026 | 19.95M |
| September 02, 2026 | 19.42M |
| September 01, 2026 | 18.96M |
| August 31, 2026 | 18.47M |
| August 28, 2026 | 17.89M |
| August 27, 2026 | 18.38M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 652.33B |
| ANI Pharmaceuticals, Inc. | 1.620B |
| Corcept Therapeutics, Inc. | 8.111B |
| Veru, Inc. | 35.29M |
| Eli Lilly & Co. | 1.292T |
Market Cap Related Metrics
| PS Ratio | 6.409 |
| PEG Ratio | -0.0068 |
| Price to Book Value | 0.5833 |
| Price | 1.54 |
| Earnings Yield | -121.0% |
| PEGY Ratio | -0.0068 |